GeekWire

OCTOBER 6, 2022

Katherine Sizov, left, CEO & co-founder of Strella Biotechnology, discusses her win in the Elevator Pitch competition at the GeekWire Summit on Thursday alongside Amina Moreau, CEO of Radious; Erin Quick, co-founder and CEO of PairTree; Devin Miller, co-founder and CEO of SecureSave; and GeekWire co-founder John Cook.

Biotechnology 69

Biotechnology Apple Transportation Groups 69

GeekWire

JANUARY 13, 2021

Less than three years after it was founded and with no revenue on the books, Sana Biotechnology has f iled to go public. And like many biotechnology companies it is losing money. Sana would become the latest in a string of Seattle area biotechnology companies to join the public ranks in recent months. stake in Sana.

Biotechnology 123

Biotechnology Applications .Net Government 123

GeekWire

MARCH 9, 2022

Adaptive Biotechnologies has a new CFO. Tycho Peterson, Adaptive’s new CFO. Morgan Chase Photo). Tycho Peterson comes from J.P. Morgan Chase, where he most recently served in its healthcare group as managing director, life science tools and diagnostics.

Biotechnology 88

Biotechnology Healthcare Open Source Sports 88

GeekWire

FEBRUARY 15, 2022

Adaptive Biotechnologies , which develops technology to assess the immune response, posted $154.3 Adaptive moved into its new headquarters in September. Co-founders Harlan (left) and Chad Robins on the new plaza. GeekWire Photo / Charlotte Schubert). million in revenue last year, a 57% year-over-year increase.

Biotechnology 83

Biotechnology .Net Development Report 83

GeekWire

FEBRUARY 3, 2021

Sana Biotechnology — the Seattle upstart that’s looking to treat a variety of diseases through gene therapy and cell engineering — is generating buzz on Wall Street. That would net the biotechnology company $517 million if it sold at the midpoint of that range. Sana’s technology (screen grab via IPO filing).

Biotechnology 91

Biotechnology .Net Engineering Applications 91

GeekWire

FEBRUARY 1, 2021

Adaptive Biotechnologies). Adaptive Biotechnologies has promoted one exec, while another is departing next month. Adaptive Biotechnologies’ EVP of Operations and Management Nancy Hill will depart the company in March. Bevier joined the F5 board in 2006. Mark Adams. Mark Adams is now COO.

Biotechnology 105

Biotechnology Telecommunications Financial Architecture 105

GeekWire

FEBRUARY 8, 2021

Nautilus Biotechnology co-founders Sujal Patel (left) and Parag Mallick. Nautilus Biotechnology , a Seattle-based biotech startup led by Isilon co-founder Sujal Patel , is the latest company to go public using a special purpose acquisition company, or SPAC. Nautilus Photo).

Biotechnology 145

Biotechnology .Net Wireless Hardware 145

GeekWire

OCTOBER 19, 2021

Sana Biotechnology has a new $50 million tool in its toolbox. Sana CEO and president Steve Harr. Sana Photo). Sana signed an agreement with Beam Therapeutics for non-exclusive commercial rights to the Cambridge, Mass.-based based biotech’s gene editing system, called CRISPR-Cas12b.

Biotechnology 117

Biotechnology System Programming Engineering 117

GeekWire

NOVEMBER 10, 2020

Adaptive Biotechnologies CEO Chad Robins. Adaptive Biotechnologies beat expectations for its fiscal third quarter as the Seattle company continues to use its immune medicine platform in the fight against COVID-19. GeekWire Photo). Adaptive posted revenue of $26.3 million, up 1% year-over-year, and earnings per share of -$0.27.

Biotechnology 74

Biotechnology Pharmaceuticals Microsoft System 74

GeekWire

JULY 14, 2020

Adaptive Biotechnologies announced Tuesday that it will sell 8 million shares of its common stock — 6 million of its own, and 2 million from an investor — to help accelerate the company’s work.

Biotechnology 71

Biotechnology Development Microsoft System 71

GeekWire

SEPTEMBER 21, 2021

Adaptive co-founders Harlan (left) and Chad Robins on the plaza at the new Adaptive Biotechnology headquarters. After doubling its workforce during the pandemic, Adaptive Biotechnologies finally has room to grow. GeekWire Photos / Charlotte Schubert).

Biotechnology 98

Biotechnology Real Estate Analysis Windows 98

GeekWire

JUNE 9, 2021

Nautilus Biotechnology co-founders Sujal Patel (left) and Parag Mallick. Nautilus Biotechnology is emerging as Seattle’s newest publicly traded company this week, taking advantage of the mania over SPACs to raise $345 million to fuel a new approach that could accelerate biomedical research and transform drug development.

Biotechnology 121

Biotechnology Analysis Engineering Research 121

GeekWire

APRIL 12, 2023

Workplace of the Year finalists, clockwise from top left: Adaptive Biotechnologies co-founders Harlan and Chad Robins; the Helion team; Impinj offices in Seattle; Treasury4 team; Blink CEO Karen Clark Cole. This year’s finalists are Adaptive Biotechnologies, Blink, Helion, Impinj and Treasury4. Blink Blink CEO Karen Clark Cole.

Biotechnology 98

Biotechnology Policies Energy Meeting 98

GeekWire

OCTOBER 14, 2022

From left: Elevator Pitch finalists Amina Moreau of Radious, Devin Miller of SecureSave, Erin Quick of PairTree and Katherine Sizov of Strella Biotechnology. GeekWire Photos / Dan DeLong). Watch the brand new episode of Elevator Pitch above , and find all of this season’s episodes here.

Biotechnology 105

Biotechnology Groups Financial Security 105

GeekWire

AUGUST 23, 2021

In the previous four years, Adaptive Biotechnologies was the only Washington state biotech company to go public. Sana Biotechnology, for instance, is led by Steve Harr , former CFO and corporate development head at Juno Therapeutics, a Seattle company that went public in 2014 and was later acquired by Celgene for $9 billion.

Biotechnology 129

Biotechnology Company Software Software 129

GeekWire

OCTOBER 1, 2022

From left: Strella Biotechnology CEO Katherine Sizov, BattGenie CEO Manan Pathak, and Aquagga CEO Nigel Sharp. GeekWire Photo / Kevin Lisota). GeekWire’s Elevator Pitch startup competition is back with the final episode of the season, featuring three entrepreneurs pitching their sustainability-focused startups.

Biotechnology 85

Biotechnology Chemicals Groups Applications 85

GeekWire

JULY 8, 2021

Absci is the latest in a string of Washington state biotech startups to test the public markets — others including Impel Neuropharma, Sana Biotechnology, Athira Pharma, and Silverback Therapeutics have had IPOs in the past year. The amount of investment that is pouring into biotechnology and the life sciences is incredible,” said Alexandre.

Biotechnology 132

Biotechnology Industry Real Estate Company 132

GeekWire

JULY 27, 2020

Chad Robins, CEO of Adaptive Biotechnologies, speaks at the site of the company’s future corporate headquarters in Seattle, standing in front of the final piece of structural steel before it’s put into place. Stephen Brashear/AP Images for Adaptive Biotechnologies). Stephen Brashear/AP Images for Adaptive Biotechnologies).

Biotechnology 102

Biotechnology Real Estate Industry Microsoft 102

GeekWire

APRIL 15, 2021

Chad Robins, left, is co-founder and CEO of Adaptive Biotechnologies, which he co-founded with his brother, Harlan Robins, right, a theoretical physicist turned computational biologist who is the company’s chief scientific officer. Adaptive Biotechnologies Photo).

Biotechnology 87

Biotechnology Web Services Education Insurance 87

GeekWire

APRIL 18, 2023

The category highlights pioneering health, life science, biotechnology or medical breakthroughs that hold great promise for bettering our lives or improving the healthcare system. A fifth company is the brainchild of a founder previously at Pacific Northwest Research Institute (PNRI).

Biotechnology 113

Biotechnology Healthcare Artificial Intelligence Software 113

GeekWire

JANUARY 14, 2022

The Bill & Melinda Gates Foundation has committed $40 million in equity investment and $10 million in grant funding to Vir Biotechnology for the development of therapies against HIV and Malaria, Vir announced Friday. government has been buying to fight Omicron.

Biotechnology 107

Biotechnology Government Research Development 107

GeekWire

JULY 29, 2021

The amount of investment that is pouring into biotechnology and the life sciences is incredible,” said Leslie Alexandre, CEO of Life Sciences Washington. Biotech IPOs reached an all-time high last year, according to Biopharma Dive , and the pace is continuing into 2021.

Biotechnology 140

Biotechnology Company Pharmaceuticals Research 140

ComputerWorld IT Management

DECEMBER 13, 2022

As a leader in the biotechnology industry, Genentech is particularly invested in its own employees’ wellness, taking a holistic approach that cuts across career growth; social well-being; and financial, physical, and mental health.

Biotechnology 88

Biotechnology Financial Resources Social 88

GeekWire

OCTOBER 2, 2022

The four finalists in Season 3 of GeekWire’s Elevator Pitch competition, clockwise from upper left: Erin Quick, co-founder and CEO of PairTree, Katherine Sizov, CEO & co-founder of Strella Biotechnology, Amina Moreau, CEO of Radious, and Devin Miller, co-founder and CEO of SecureSave, (GeekWire Photos / Kevin Lisota).

Biotechnology 77

Biotechnology Apple Google Financial 77

GeekWire

JUNE 30, 2021

The company, founded in 2011, began commercial operations in 2018 and now has partnerships with Merck, Xyphos Biotechnology, Alpha Cancer Technologies and several other drug companies. Three Washington state companies — Sana Biotechnology , Impel Neuropharma and Paymentus — have gone public with a traditional IPO this year.

Biotechnology 127

Biotechnology Company .Net Programming 127

Gizmodo

JULY 14, 2021

An expert committee says heritable genome editing of humans is still too risky and that the World Health Organization should take on a leading role when it comes to regulating this emerging biotechnology. Read more.

Biotechnology 79

Biotechnology Engineering 79

GeekWire

AUGUST 11, 2021

So how do Washington state’s technology and biotechnology companies measure up? However, Adaptive Biotechnologies went public only two years ago, and it appears the rule does not apply for the first four to five years after an IPO. RELATED: The push for corporate board diversity is growing. Seemingly better.

Biotechnology 103

Biotechnology Company Microsoft Meeting 103

GeekWire

DECEMBER 30, 2020

In June, Seattle biotechnology upstart Sana Biotechnology revealed that it had raised more than $700 million in venture funding. Which of these Washington state companies did NOT go public in 2020: Accolade, Adaptive Biotechnologies, Athira Pharma, Silverback Therapeutics? Adaptive Biotechnologies (It went public in 2019).

Biotechnology 134

Biotechnology Sports Microsoft Cloud 134

GeekWire

NOVEMBER 7, 2022

Laura Cooper , previously senior director of corporate communications at Adaptive Biotechnologies, joined Day One Biopharmaceuticals as head of corporate communications. Pittenger remained at Cint as CTO for about a year before joining DexCare in November.

Biotechnology 89

Biotechnology Nonprofit Healthcare Research 89

GeekWire

NOVEMBER 13, 2020

Adaptive Biotechnologies says it’s proceeding with plans to launch a new type of test to determine if someone was previously infected with SARS-CoV-2, the virus that causes COVID-19, after a study added to the evidence that its approach is more accurate than currently available antibody tests. Adaptive Biotechnologies Photo).

Biotechnology 138

Biotechnology Comparison Microsoft .Net 138

GeekWire

MARCH 1, 2023

The layoffs are the latest to hit biopharma in Washington state, which has seen workforce cuts at Absci , Zymeworks , TwinStrand Biosciences , NanoString Technologies and Sana Biotechnology , among other companies.

Artificial Intelligence 110

Artificial Intelligence Biotechnology Research Security 110

GeekWire

MARCH 10, 2023

The news is a bright spot for Seattle’s biopharma scene which has seen employee cuts at several biotech companies recently as part of wider layoffs in the industry, including at NanoString Technologies , Sana Biotechnology , Eliem Therapeutics and Neoleukin Therapeutics.

Artificial Intelligence 84

Artificial Intelligence Biotechnology Microsoft Cloud 84

GeekWire

FEBRUARY 26, 2021

This was a first-of-its kind diagnostic tool from Seattle-based Adaptive Biotechnologies , a company that develops technology to sequence the human immune system for the diagnosis and treatment of disease. Adaptive Biotechnologies’ new test, called T-Detect COVID , was developed in partnership with Microsoft.

Biotechnology 140

Biotechnology System Microsoft Study 140

GeekWire

DECEMBER 29, 2022

Strella Biotechnology Co-founder and CEO Katherine Sizov won GeekWire’s Elevator Pitch startup competition at the 2022 GeekWire Summit, with a unique sensing technology that reduces food waste by determining what? GeekWire story: Elevator Pitch winner Strella Biotechnology has a ripe idea for solving major food waste problem.

Biotechnology 109

Biotechnology Apple Transportation Video 109

GeekWire

APRIL 16, 2021

The category highlights pioneering health, life science, biotechnology or medical breakthroughs that hold great promise for bettering our lives or improving the healthcare system. Adaptive Biotechnologies. So it’s little wonder that there’s stiff competition for the 2021 GeekWire Health Innovation of the Year.

Biotechnology 122

Biotechnology Artificial Intelligence Virtualization Healthcare 122

GeekWire

JULY 2, 2020

OncoSenX is the spinoff of a third company, Seattle-based Oisin Biotechnologies. The researchers said they have selected the two most promising DNA sequences for further testing. Researchers at OncoSenX are using Fusogenix for cancer research on the treatment of solid tumors.

Research 144

Research Biotechnology Pharmaceuticals Development 144

GeekWire

JANUARY 10, 2022

Adaptive Biotechnologies Photo). Chad Cohen will step down as CFO of Adaptive Biotechnologies on Feb. Chad Cohen. Prior to joining Adaptive in 2015, Cohen was CFO of Zillow Group. Principal accounting officer Kyle Piskel will serve as interim CFO after Cohen resigns.

Biotechnology 98

Biotechnology Microsoft Real Estate Journal 98